Non-Invasive Prenatal Test

The Non-Invasive Prenatal Test (NIPT) is a blood test that can be used to screen for genetic conditions in the fetus, such as Down syndrome, trisomy 18, trisomy 13, and other microdeletions. NIPT is a highly accurate and safe test, with no risk of miscarriage. It can be done as early as 10 weeks of pregnancy.

We offer two types of Non-Invasive Prenatal Tests (NIPTs)

Both NIPT tests are highly accurate (>99%) and safe, with no risk of miscarriage. The results of the test can help parents make informed decisions about possible treatments and clinical management.

It is a valuable tool that can help parents learn more about the health of their fetus. It is important to talk to your doctor about NIPT and whether it is right for you.

NIPT for common fetal aneuploidies & microdeletions

This test is recommended for all pregnant women, regardless of age or risk category. It can be done from the 10th week of pregnancy and tests for the most common fetal aneuploidies (Down syndrome, trisomy 18, and trisomy 13) and microdeletions (22q11.2 deletion syndrome, 1p36 deletion syndrome, and Cri-du-chat syndrome).

NIPT for other microdeletions & monogenic diseases

This test is recommended for pregnant women who want to screen for other microdeletions and monogenic diseases that can have a significant impact on life quality, but are not associated with maternal age. This test can also be done from the 10th week of pregnancy.
NIPT works by analyzing cell-free DNA from the mother’s blood. Cell-free DNA is small fragments of DNA that are released into the bloodstream by cells throughout the body, including the placenta. The placenta is the organ that connects the fetus to the mother and provides the fetus with nutrients and oxygen.
NIPT tests are screening tests, which means that they cannot provide a definitive diagnosis of a genetic condition. However, they can provide a high or low risk for certain conditions. If an NIPT test result shows an increased risk for a genetic condition, further diagnostic testing, such as chorionic villus sampling (CVS) or amniocentesis, may be recommended.

NIPT is recommended for all pregnant women, regardless of age or risk category. However, it is especially important for women who are at an increased risk for having a baby with a genetic condition, such as women who are over the age of 35, women who have a family history of genetic conditions, or women who have had a previous pregnancy with a genetic condition.

The results of an NIPT test can help parents make informed decisions about their pregnancy. For example, if an NIPT test result shows a high risk for Down syndrome, parents may choose to have further diagnostic testing to confirm the diagnosis. Or, they may choose to prepare for the possibility of having a child with Down syndrome.